SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-09-024974
Filing Date
2009-11-06
Accepted
2009-11-06 07:16:01
Documents
11
Period of Report
2009-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 30568
2 NRGN LOGO logo.jpg GRAPHIC 6619
3 PRESS RELEASE DATED NOVEMBER 6, 2009 exhibit991.htm EX-99.1 171032
4 AMENDMENT TO AGREEMENT AND PLAN OF MERGER exhibit21.htm EX-2.1 967
5 SIGNATURE PAGE 1 TO EXHIBIT 2.1 signature1.jpg GRAPHIC 89107
6 SIGNATURE PAGE 2 TO EXHIBIT 2.1 signature2.jpg GRAPHIC 187617
7 SIGNATURE PAGE 3 TO EXHIBIT 2.1 signature3.jpg GRAPHIC 187578
8 SIGNATURE PAGE 4 TO EXHIBIT 2.1 signature4.jpg GRAPHIC 136035
9 AMENDMENT TO AGREEMENT AND PLAN OF MERGER exhibit21.jpg GRAPHIC 185370
10 AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGER exhibit22.htm EX-2.2 515
11 AMENDMENT NO.2 TO AGREEMENT AND PLAN OF MERGER exhibit22.jpg GRAPHIC 245678
  Complete submission text file 0001140361-09-024974.txt   1635945
Mailing Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405 2034888201
NEUROGEN CORP (Filer) CIK: 0000849043 (see all company filings)

IRS No.: 222845714 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-18311 | Film No.: 091162768
SIC: 2834 Pharmaceutical Preparations